Throughout the medical device industry, corporations are continually looking to reduce the overall cost of producing high-quality medical devices, and look towards quality assurance executives to mitigate risk and maintain pristine levels of quality all while reducing expenditures. At the same time, the FDA along with other global regulatory agencies are increasing the level of regulatory scrutiny alongside increased numbers of audits, inspections and resulting warning letters, setting industry executives unclear on how to best maintain compliance. Through a conference program designed to provide insight and clarity into leading corporations, the Q1 Medical Device Quality Assurance program will provide executives with an unrivaled educational and networking platform.